Segal Institute for Clinical Research

Segal Institute for Clinical Research, widely known as Segal Trials, is a premier clinical research site network specializing in Phase I-IV clinical trials. Founded in 1998, the organization has established itself as a leader in Central Nervous System (CNS) research, covering psychiatry, neurology, and addiction medicine, while also maintaining expertise in women's health and general medicine. The institute operates a network of specialized facilities, including inpatient units and outpatient clinics across Florida and South Carolina. In 2021, Segal Trials was acquired by CenExel Clinical Research, integrating its high-enrollment capabilities into a broader national network. The company is recognized for its robust patient recruitment strategies and high-quality data management for global pharmaceutical and biotech sponsors.